ENIS ROSIC: Open Payments
NPI 1710498670 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,119 in 88 payments from 17 companies in 2025. Trend: 2023 $2,433 · 2024 $2,498 · 2025 $2,119
Food & beverage: $2,120
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 37 | $698 |
| Inspire Medical Systems, Inc. | 5 | $325 |
| Axsome Therapeutics, Inc. | 8 | $323 |
| GENZYME CORPORATION | 6 | $167 |
| Merck Sharp & Dohme LLC | 5 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $94 |
| Grifols USA, LLC | 5 | $82 |
| Actelion Pharmaceuticals US, Inc. | 3 | $67 |
| Philips North America LLC | 4 | $64 |
| Regeneron Healthcare Solutions, Inc. | 2 | $38 |
Products named: NUCALA, INSPIRE, Sunosi, DUPIXENT, TRELEGY ELLIPTA, WINREVAIR, GLASSIA, Prolastin-C Liquid.
Industry payments across KY — which companies pay providers there.
